Melanoma Clinical Trials in Anchorage, AK
As of June 2026, 2 paid clinical trials are recruiting for Melanoma in Anchorage, Alaska. Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Anchorage
Filter results
2 clinical trials for Melanoma
·Clear filters·↓ Download CSVA Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
About research studies in Anchorage
Anchorage has approximately 113 recruiting research studies across a wide range of therapeutic areas. Alaska hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Anchorage
Researchers run research studies in Anchorage, AK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Alaska Medical Center | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Breast Cancer | 56 |
| Alaska Women's Cancer Care | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 47 |
| Katmai Oncology Group | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Recurrent Lung Non-Small Cell Carcinoma | 47 |
| Alaska Oncology and Hematology LLC | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 42 |
| Alaska Breast Care and Surgery LLC | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 41 |
| Anchorage Associates in Radiation Medicine | Malignant Solid Neoplasm, Breast Cancer, Chronic Lymphocytic Leukemia | 41 |
| Anchorage Radiation Therapy Center | Breast Cancer, Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm | 32 |
| Anchorage Oncology Centre | Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain | 30 |
| Alaska Oncology and Hematology | Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 7 |
| Alaska Heart Institute | Obstructive Hypertrophic Cardiomyopathy, Paroxysmal Atrial Fibrillation | 2 |
| Alaska Native Tribal Health Consortium | Child Obesity, Smoking Cessation | 2 |
| Alaska Oncology & Hematology, LLC | B-Cell Non-Hodgkins Lymphoma, Non-small Cell Lung Cancer | 2 |
| Alaska Oncology and Hematology, LLC | Non-small Cell Lung Cancer, Solid Tumours | 2 |
| Southcentral Foundation | Advance Care Planning, Hearing Loss | 2 |
| AA Spine & Pain Clinic | Lumbar Spinal Stenosis | 1 |
| Alaska Children's EYE & Strabismus | Bradycardia, Strabismus | 1 |
| Alaska Heart and Vascular Institute | Symptomatic Hypertrophic Cardiomyopathy (HCM) | 1 |
| Alaska Native Medical Center (ANMC) | Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III | 1 |
| Alaska Oncology and Hematology ( Site 0039) | Non-small Cell Lung Cancer | 1 |
| Alaska Women's Cancer Care ( Site 0096) | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 1 |
| Alaska Women's Cancer Care ( Site 6036) | Endometrial Cancer | 1 |
| Alaska Women's Cancer Center | Endometrial Adenocarcinoma | 1 |
| Alaska Womens Cancer Care | Endometrial Cancer | 1 |
| Alaska Womens Cancer Care ( Site 0037) | Malignant Neoplasm | 1 |
| Alaska Womens Cancer Care Akwcc | Ovarian Cancer | 1 |
Active & Upcoming Studies in Anchorage (2026)
Recruiting trials in Anchorage grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (79 active studies)
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · Fred Hutchinson Cancer Center
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Cardiovascular (3 active studies)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
- STOP AF First Post-Approval Study · Medtronic Cardiac Ablation Solutions
Mental health & behavior (2 active studies)
- Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT) · Southcentral Foundation
- Family-Based Financial Incentives Intervention for Smoking Cessation · Mayo Clinic
Diabetes & metabolic (1 active study)
- More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers · Alaska Native Tribal Health Consortium
Pediatric (1 active study)
Common conditions studied in Anchorage
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage III Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Gastroesophageal Junction Adenocarcinoma (3 active studies). Recruiting Gastroesophageal Junction Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Anchorage
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Alaska are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Alaska research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Anchorage. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Anchorage
Hipa.ai aggregates every recruiting study in Anchorage from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Anchorage?
There are approximately 113 recruiting clinical trials in Anchorage, Alaska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Anchorage pay participants?
Most recruiting trials in Anchorage compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Anchorage?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Anchorage?
The most common conditions under active study in Anchorage include Malignant Solid Neoplasm (5), Breast Cancer (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Anatomic Stage III Breast Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Anchorage?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Anchorage on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Anchorage?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Anchorage?
Recruiting research sites in Anchorage include Providence Alaska Medical Center, Alaska Women's Cancer Care, Katmai Oncology Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Anchorage right now?
The largest active categories in Anchorage are Cancer & tumors (79), Cardiovascular (3), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.